Troponin I-C activators include a variety of compounds that indirectly enhance the functional activity of Troponin I-C, a key protein in cardiac muscle contraction regulation. These activators function by influencing signaling pathways and cellular processes associated with cardiac function. Compounds such as beta-adrenergic agonists and phosphodiesterase inhibitors work by increasing cardiac contractility and heart rate, which can lead to enhanced Troponin I-C activity as the heart muscle responds to increased functional demand.
In addition to these direct cardiac function modulators, other compounds can influence Troponin I-C activity by affecting calcium dynamics within cardiac cells. Agents that increase intracellular calcium levels or enhance the sensitivity of cardiac muscle to calcium can activate Troponin I-C. This includes cardiac glycosides and certain herbal extracts known to modulate heart function. The indirect activation of Troponin I-C through these mechanisms is critical in regulating the heart's contractile response, highlighting the importance of Troponin I-C in cardiovascular health and disease. By targeting various components and regulators of cardiac muscle contraction and calcium signaling, these activators provide insights into the modulation of key proteins involved in heart function.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol Hydrochloride is a beta-adrenergic agonist that can enhance cardiac muscle contraction, potentially leading to increased activation of Troponin I-C. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
(-)-Epinephrine, another beta-adrenergic agonist, stimulates heart rate and force of contraction, potentially influencing Troponin I-C activity. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine Hydrochloride can increase cardiac contractility, potentially activating Troponin I-C. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Caffeine increases intracellular calcium levels, which could enhance the sensitivity of Troponin I-C to calcium, thereby increasing its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin elevates cAMP levels, leading to enhanced cardiac contractility and potentially increased Troponin I-C activity. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $162.00 $683.00 | 7 | |
Milrinone, a phosphodiesterase inhibitor, increases cAMP in cardiac cells, potentially enhancing Troponin I-C activity. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Berberine can modulate cardiac function and might influence Troponin I-C activity. | ||||||
Ivabradine hydrochloride | 148849-67-6 | sc-507513 | 10 mg | $120.00 | ||
Ivabradine, by reducing heart rate, can indirectly affect the functional demand on Troponin I-C. | ||||||
Levosimendan | 141505-33-1 | sc-204792 sc-204792A | 100 mg 250 mg | $102.00 $224.00 | ||
Levosimendan enhances cardiac contractility and sensitivity to calcium, potentially activating Troponin I-C. | ||||||
Amrinone | 60719-84-8 | sc-207288 | 1 g | $193.00 | ||
Amrinone, a phosphodiesterase inhibitor, increases cardiac contractility, potentially influencing Troponin I-C activity. |